|
Taj Pharmaceuticals
Ltd is keen to capitalize on new opportunities emerging in the
generics market.
The company is right now focusing
on dermatology, respiratory and cardiovascular segments. "We are
focusing on treatment of pain, inflammation and metabolic
disorders through new chemical entity research, while on biologics
front, we are focusing on technology and inflammation
Despite such a big opportunity for future, the market also has a
number challenges to deal with. Generic drugs are still regarded
as cheap, low quality alternatives of branded drugs. Thus, both
physicians and patients are skeptic regarding their safety and
efficacy.
As generic drug suppliers search
for ways to increase the marketability and positioning of their
products, the number of controlled release technology formulations
entering the marketplace will accelerate.
Drug formulation technology companies are
working with drug developers to help define the prescription
formulations that will enter preclinical development and the
clinical trial.
For many of these areas and the corresponding indications,
Taj Pharmaceuticals has provided a large range of
therapeutic options. Please view a selection of major
prescription drugs by accessing the current
Selected Products
overview.
|
Quality
